Objective: To describe and analyse predictive and prognostic factors of overall survival (OS) in high-grade gliomas at our institution.
Material And Method: All patients diagnosed with grade iii (GIII) or grade iv (GIV) gliomas (excluding oligodendrogliomas, oligoastrocytomas or infratentorial gliomas) were prospectively included from November 2010 to August 2014. All were treated with surgery followed by adjuvant radiochemotherapy.